Insulin-like growth factor-I induces the phosphorylation and nuclear exclusion of forkhead transcription factors in human neuroblastoma cells

Apoptosis

Volumn 10, Issue 4, 2005, Pages 831-840

  Schwab, T S ^a   Madison, B B ^a   Grauman, A R ^a   Feldman, E L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

FKHR; FKHRL1; Forkhead; IGF I; IGF IR; Neuroblastoma

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; EXPORTIN 1; GREEN FLUORESCENT PROTEIN; LEPTOMYCIN B; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; SERINE; SOMATOMEDIN C; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FKHRL1;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CYTOPLASM; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; APOPTOSIS; CELL LINE, TUMOR; CELL NUCLEUS; ENZYME ACTIVATION; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; HUMANS; INSULIN-LIKE GROWTH FACTOR I; NEUROBLASTOMA; PHOSPHORYLATION; PROTEIN TRANSPORT; RECOMBINANT FUSION PROTEINS; SUBCELLULAR FRACTIONS;

EID: 23944475155     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10495-005-0429-y     Document Type: Article

References (75)

1. Carlsen NLT. Neuroblastoma: Epidemiology and pattern of regression. Problems in interpreting results of mass screening. Amer J Ped Hematol/Oncol 1992; 14: 103-110.
2. Philip T. Overview of current treatment of neuroblastoma. Amer J Ped Hematol/Oncol 1992; 14: 97-102.
3. Nakagawara A. The NGF story and neuroblastoma. Med Ped Oncol 1998; 31: 113-115.
4. Woo CW, Lucarelli E, Thiele CJ. NGF activation of TrkA decreases N-myc expression via MAPK path leading to a decrease in neuroblastoma cell number. Oncogene 2004; 23: 1522-1530.
5. Ho R, Eggert A, Hishiki T, et al. Resistance to chemotherapy mediated by TrkB in neuroblastomas. Cancer Res 2002; 62: 6462-6466.
6. Jaboin J, Kim CJ, Kaplan DR, Thiele CJ. Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3′-kinase pathway. Cancer Res 2002; 62: 6756-6703.
7. Brodeur GM. Neuroblastoma: Biological insights into a clinical enigma. Nature Rev Cancer 2003; 3: 203-216.
8. van Golen CM, Feldman EL. Insulin-like growth factor I is the key growth factor in serum that protects neuroblastoma cells from hyperosmotic-induced apoptosis. J Cell Physiol 2000; 182: 24-32.
9. van Golen CM, Castle VP, Feldman EL. IGF-I receptor activation and Bcl-2 overexpression prevent early apoptotic events in human neuroblastoma. Cell Death and Differentiation 2000; 7: 654-665.
10. Meyer GE, Shelden E, Kim B, Feldman EL. Insulin-like growth factor I stimulates motility in human neuroblastoma cells. Oncogene 2001; 20: 7542-7550.
11. Kim B, van Golen C, Feldman EL. Insulin-like growth factor-I signaling in human neuroblastoma cells. Oncogene 2004; 23: 130-141.
12. Giorgetti S, Ballotti R, Kowalski-Chauvel A, Tartare S, Van Obberghen E. The insulin and insulin-like growth factor-I receptor substrate IRS-1 associates with and activates phosphatidylinositol 3-kinase in vitro. Journal of Biological Chemistry 1993; 268: 7358-7364.
13. Kapeller R, Cantley LC. Phosphatidylinositol 3-kinase. Bioessays 1994; 16: 565-576.
14. Pawson T. Protein modules and signalling networks. Nature 1995; 373: 573-580.
15. Davis RJ. The mitognen-activated protein kinase signal transduction pathway. Journal of Biological Chemistry 1993; 268: 14553-14556.
16. Pelech SL, Sanghera JS. Mitogen-activated protein kinases: Versatile transducers for cell signaling. Trends in the Biochemical Sciences 1992; 17: 233-238.
17. Varticovski L, Harrison-Findik D, Keeler ML, Susa M. Role of PI 3-kinase in mitogenesis. Biochimica et Biophysica Acta 1994; 1226: 1-11.
18. Cheatham B, Kahn CR. Insulin action and insulin signaling network. Endocrine Reviews 1995; 16: 117-142.
19. Seger R, Krebs EG. The MAPK signaling cascade. FASEB Journal 1995; 9: 726-735.
20. Párrizas M, Saltiel AR, LeRoith D. Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways. Journal of Biological Chemistry 1997; 272: 154-161.
21. Franke TF, Yang S-I, Chan TO, et al. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 1995; 81: 727-736.
22. Kennedy SG, Wagner AJ, Conzen SD, et al. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes and Development 1997; 11: 701-713.
23. Dudek H, Datta SR, Franke TF, et al. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 1997; 275: 661-665.
24. Coffer PJ, Jin J, Woodgett JR. Protein kinase B (c-Akt): A multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochemical Journal 1998; 335(Pt 1): 1-13.
25. Andjelkovic M, Alessi DR, Meier R, et al. Role of translocation in the activation and function of protein kinase B. Journal of Biological Chemistry 1997; 272: 31515-31524.
26. Burgering BMT, Coffer PJ. Protein kinsase B (c-Akt) in phosphatidylinositol 3-OH kinase signal transduction. Nature 1995; 376: 599-602.
27. Kulik G, Klippel A, Weber MJ. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Molecular Cell Biology 1997; 17: 1595-1606.
28. Ahmed NN, Grimes HL, Bellacosa A, Chan TO, Tsichlis PN. Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proceedings of the National Academy of Sciences of the USA 1997; 94: 3627-3632.
29. Datta SR, Brunet A, Greenberg ME. Cellular survival: A play in three Akts. Genes and Development 1999; 13: 2905-2927.
30. Meier R, Alessi DR, Cron P, Andjelkovic M, Hemmings BA. Mitogenic activation, phosphorylation, and nuclear translocation of protein kinase Bbeta. J Biol Chem 1997; 272: 30491-30497.
31. Paradis S, Ruvkun G. Caenorhabditis elegans Akt/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor. Genes and Development 1998; 12: 2488-2498.
32. Galili N, Davis RJ, Fredericks WJ, et al. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma [published erratum appears in Nat Genet 1994; 6(2): 214]. Nature Genetics 1993; 5: 230-235.
33. Davis RJ, Bennicelli JL, Macina RA, Nycum LM, Biegel JA, Barr FG. Structural characterization of the FKHR gene and its rearrangement in alveolar rhabdomyosarcoma. Human Molecular Genetics 1995; 4: 2355-2362.
34. Hillion J, Le Coniat M, Jonveaux P, Berger R, Bernard OA. AF6q21, a novel partner of the MLL gene in t(6;11)(q21;q23), defines a forkhead transcriptional factor subfamily. Blood 1997; 90: 3714-3719.
35. Anderson MJ, Viars CS, Czekay S, Cavenee WK, Arden KC. Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily. Genomics 1998; 47: 187-199.
36. Borkhardt A, Repp R, Haas OA, et al. Cloning and characterization of AFX, the gene that fuses to MLL in acute leukemias with a t(X;11)(q13;q23). Oncogene 1997; 14: 195-202.
37. Brunet A, Bonni A, Zigmond MJ, et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999; 96: 857-868.
38. Rena G, Guo S, Cichy SC, Unterman TG, Cohen P. Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B. J. Biol. Chem. 1999; 274: 17179-17183.
39. Kops GJ, de Ruiter ND, De Vries-Smits AM, Powell DR, Bos JL, Burgering BM. Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 1999; 398: 630-634.
40. Tang ED, Nunez G, Barr FG, Guan KL. Negative regulation of the forkhead transcription factor FKHR by Akt. J. Biol. Chem. 1999; 274: 16741-16746.
41. Nakae J, Park BC, Accili D. Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a Wortmannin-sensitive pathway. Journal of Biological Chemistry 1999; 274: 15982-15985.
42. Nakae J, Barr V, Accili D. Differential regulation of gene expression by insulin and IGF-1 receptors correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR. EMBO Journal 2000; 19: 989-996.
43. Biggs WH, Meisenhelder J, Hunter T, Cavenee WK, Arden KC. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proceedings of the National Academy of Sciences of the USA 1999; 96: 7421-7426.
44. Kashii Y, Uchida M, Kirito K, et al. A member of Forkhead family transcription factor, FKHRL1, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt activation pathway in erythropoietin signal transduction. Blood 2000; 96: 941-949.
45. Takaishi H, Konishi H, Matsuzaki H, et al. Regulation of nuclear translocation of forkhead transcription factor AFX by protein kinase B. Proceedings of the National Academy of Sciences of the USA 1999; 96: 11836-11841.
46. Nakamura N, Ramaswamy S, Vazquez F, Signoretti S, Loda M, Sellers WR. Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Molecular Cell Biology 2000; 20: 8969-8982.
47. del Peso L, Gonzalez VM, Hernandez R, Barr FG, Nunez G. Regulation of the forkhead transcription factor FKHR, but not the PAX3-FKHR fusion protein, by the serine/threonine kinase Akt. Oncogene 1999; 18: 7328-7333.
48. Matthews CC, Feldman EL. Insulin-like growth factor I rescues SH-SY5Y human neuroblastoma cells from hyperosmotic induced programmed cell death. Journal of Cellular Physiology 1996; 166: 323-331.
49. Guo S, Rena G, Cichy S, He X, Cohen P, Unterman T. Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence. J Biol Chem 1999; 274: 17184-17192.
50. Vlahos CJ, Matter WF, Hui KY, Brown RF. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4- one(LY294002). J. Biol. Chem. 1994; 269: 5241-5248.
51. Braunstein GD, Reviczky AL. Serum insulin-like growth factor-I levels in amyotrophic lateral sclerosis. Journal of Neurology. Neurosurgery and Psychiatry 1987; 50: 792-794.
52. Ullman KS, Powers MA, Forbes DJ. Nuclear export receptors: From importin to exportin. Cell 1997; 90: 967-970.
53. Nishi K, Yoshida M, Fujiwara D, Nishikawa M, Horinouchi S, Beppu T. Leptomycin B targets a regulatory cascade of crm1, a fission yeast nuclear protein, involved in control of higher order chromosome structure and gene expression. Journal of Biological Chemistry 1994; 269: 6320-6324.
54. Kudo N, Matsumori N, Taoka H, et al. Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region. Proceedings of the National Academy of Sciences of the USA 1999; 96: 9112-9117.
55. Brownawell AM, Kops GJ, Macara IG, Burgering BM. Inhibition of nuclear import by protein kinase B (Akt) regulates the subcellular distribution and activity of the forkhead transcription factor AFX. Molecular Cell Biology 2001; 21: 3534-3546.
56. Singleton JR, Randolph AE, Feldman EL. Insulin-like growth factor I receptor prevents apotosis and enhances neuroblastoma tumorigenesis. Cancer Research 1996; 56: 4522-4529.
57. Matthews CC, Odeh H, Feldman EL. Insulin-like growth factor-I is an osmoprotectant in human neuroblastoma cells. Neuroscience 1997; 79: 525-534.
58. Cheng H-L, Steinway M, Delaney CL, Franke TF, Feldman EL. IGF-I promotes Schwann cell motility and survival via activation of Akt.Molecular and Cellular Endocrinology 2000; 170: 211-215.
59. Delaney CL, Cheng H-L, Feldman EL. Insulin-like growth factor-I prevents caspase mediated apoptosis in Schwann cells. Journal of Neurobiology 1999; 41: 540-548.
60. Russell JW, Feldman EL. Insulin-like growth factor-I prevents apoptosis in sympathetic neurons exposed to high glucose. Hormone and Metabolic Research 1999; 31: 90-96.
61. Russell JW, Windebank AJ, Schenone A, Feldman EL. Insulin-like growth factor-I prevents apoptosis in neurons after nerve growth factor withdrawal. Journal of Neurobiology 1998; 36: 455-467.
62. Westfall SD, Hendry IR, Obholz KL, Rueda BR, Davis JS. Putative role of the phosphatidylinositol 3-kinase-Akt signaling pathway in the survival of granulosa cells. Endocrine 2000; 12: 315-321.
63. Kulik G, Weber MJ. Akt-dependent and -independent survival signaling pathways utilized by insulin-like growth factor I. Molecular and Cellular Biology 1998; 18: 6711-6718.
64. Kim B, Leventhal PS, Saltiel AR, Feldman EL. Insulin-like growth factor-I-mediated neurite outgrowth in vitro requires MAP kinase activation. J. Biol. Chem. 1997; 272: 21268-21273.
65. Kim B, Feldman EL. Differential regulation of focal adhesion kinase and mitogen-activated protein kinase tyrosine phosphorylation during insulin-like growth factor-I-mediated cytoskeletal reorganization. Journal of Neurochemistry 1998; 71: 1333-1336.
66. Kim B, Leventhal PS, White MF, Feldman EL. Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells. Endocrinology 1998; 139: 4881-4889.
67. Zheng WH, Kar S, Quirion R. Insulin-like growth factor-1-induced phosphorylation of the forkhead family transcription factor FKHRL1 is mediated by akt kinase in PC12 cells. J. Biol. Chem. 2000; 275: 39152-39158.
68. Uddin S, Kottegoda S, Stigger D, Platanias LC, Wickrema A. Activation of the Akt/FKHRL1 pathway mediates the anti-apoptotic effects of erythropoietin in primary human erythroid progenitors. Biochemical and Biophysical Research Communications 2000; 275: 16-19.
69. Mitsiades CS, Mitsiades N, Poulaki V, et al. Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: Therapeutic implications. Oncogene 2002; 21: 5673-5683.
70. Zheng WH, Kar S, Quirion R. Insulin-like growth factor-1-induced phosphorylation of transcription factor FKHRL1 is mediated by phosphatidylinositol 3-kinase/Akt kinase and role of this pathway in insulin-like growth factor-1-induced survival of cultured hippocampal neurons. Molecular Pharmacology 2002; 62: 225-233.
71. Durham SK, Suwanichkul A, Scheimann AO, et al. FKHR binds the insulin response element in the insulin-like growth factor binding protein-1 promoter. Endocrinology 1999; 140: 3140-3146.
72. Haynes RB, McKibbon KA, Fitzgerald D, Guyatt GH, Walker CJ, Sackett DL. How to keep up with the medical literature: I. Why try to keep up and how to get started. Annals of Internal Medicine 1986; 105: 149-153.
73. Jackson JG, Kreisberg JI, Koterba AP, Yee D, Brattain MG. Phosphorylation and nuclear exclusion of the forkhead transcription factor FKHR after epidermal growth factor treatment in human breast cancer cells. Oncogene 2000; 19: 4574-4581.
74. Leinninger GM, Backus C, Uhler MD, Lentz SI, Feldman EL. Phosphatidylinositol 3-kinase and Akt effectors mediate insulin-like growth factor-I neuroprotection in dorsal root ganglia neurons. FASEB Journal 2004; 18: 1544-1546.
75. Richards JS, Sharma SC, Falender AE, Lo YH. Expression of FKHR, FKHRL1, and AFX Genes in the Rodent Ovary: Evidence for Regulation by IGF-I, Estrogen, and the Gonadotropins. Molecular Endocrinology 2002; 16: 580-599.